stem cells

J&J turns its back on Capricor and its failed stem cell tech, taking its money and rep with it
J&J turns its back on Capricor and its failed stem cell tech, taking its money and rep with it
Endpoints
JNJ
Capricor
stem cells
Linda Marban
Flag link:
New Texas Law on Stem Cell Treatments: Showdown With FDA Coming?
New Texas Law on Stem Cell Treatments: Showdown With FDA Coming?
RAPS.org
Texas
FDA
stem cells
Flag link:
Athersys And Aurinia Target Human And Animal Health
Athersys And Aurinia Target Human And Animal Health
Seeking Alpha
Athersys
Aurinia Pharmaceuticals
animal health
stem cells
Flag link:
Texas on track to become first state to explicitly back stem cell therapies
Texas on track to become first state to explicitly back stem cell therapies
Stat
Texas
stem cells
Flag link:
Five months, $98.5M and a PhII drug from Novartis later, Magenta Therapeutics is flooring it
Five months, $98.5M and a PhII drug from Novartis later, Magenta Therapeutics is flooring it
Endpoints
Magenta Therapeutics
Novartis
stem cells
HSC835
Flag link:
How AbbVie Is Attacking Tumors at Their Roots
How AbbVie Is Attacking Tumors at Their Roots
Motley Fool
AbbVie
solid tumors
cancer
stem cells
Stemcentrx
Rova-T
Flag link:
Three patients blinded by stem cell procedure, physicians say
Three patients blinded by stem cell procedure, physicians say
Stat
US Stem Cell
stem cells
clinical trials
macular degeneration
Flag link:
9 cardiology breakthroughs you need to know
9 cardiology breakthroughs you need to know
Mass Device
cardiology
Prevencio
Medtronic
3D printing
robotic heart sleeve
devices
aortic stenosis
stem cells
pacemakers
Flag link:
Takeda, TiGenix stem cell therapy shows sustained effect
Takeda, TiGenix stem cell therapy shows sustained effect
Fierce Biotech
Takeda
TiGenix
stem cells
Cx601
Crohn's Disease
Flag link:
Orthocell, J&J’s DePuy Synthes ink R&D deal for stem cell treatment
Orthocell, J&J’s DePuy Synthes ink R&D deal for stem cell treatment
Mass Device
Orthocell
JNJ
DePuy Synthes
R&D
stem cells
devices
Flag link:
STAT’s stats of the year: 2016 by the numbers
STAT’s stats of the year: 2016 by the numbers
Stat
Pharma
biotech
drug ads
stem cells
CRISPR
Medicare
Zika virus
venture capital
Flag link:
Once-promising diabetes ‘breakthrough’ comes unglued with a major retraction
Once-promising diabetes ‘breakthrough’ comes unglued with a major retraction
Stat
diabetes
stem cells
Regeneron
Flag link:
Bayer, Versant close $225m Series A to launch stem cell company
Bayer, Versant close $225m Series A to launch stem cell company
Mass Device
Bayer
Versant Ventures
stem cells
Series A
BlueRock Therapeutics
devices
regenerative medicine
Flag link:
FDA chief pushes back against criticism of stem cell treatment regulations
FDA chief pushes back against criticism of stem cell treatment regulations
Stat
FDA
stem cells
Robert Califf
Flag link:
FDA OKs stem cell-gene therapy trial for ALS
FDA OKs stem cell-gene therapy trial for ALS
Drug Delivery Business
FDA
stem cells
gene therapy
ALS
Flag link:
FDA weighs crackdown that could shut hundreds of stem cell clinics
FDA weighs crackdown that could shut hundreds of stem cell clinics
Stat
FDA
stem cells
stem cell clinics
Flag link:
Rapunzel startup aims to treat female hair loss using stem cells
Rapunzel startup aims to treat female hair loss using stem cells
Stat
alopecia
hair loss
Rapunzel
stem cells
Flag link:
Cartilage grown from stem cells could replace hip implants
Cartilage grown from stem cells could replace hip implants
Fierce Biotech
devices
cartilage
stem cells
Cytex Therapeutics
hip implants
Flag link:
Brainstorm: New ALS Stem Cell Results Support Start of Pivotal Clinical Trial
Brainstorm: New ALS Stem Cell Results Support Start of Pivotal Clinical Trial
TheStreet.com
BrainStorm Cell Therapeutics
stem cells
clinical trials
ALS
NurOwn
Flag link:
Israeli firms claim 3-D stem cell printing advance, plan spin out
Israeli firms claim 3-D stem cell printing advance, plan spin out
Fierce Biotech
Israel
3D printing
Nano Dimension
Accellta
devices
stem cells
Flag link: